PuSH - Publication Server of Helmholtz Zentrum München

36 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
O'Leary, V.B. ; Ovsepian, S.V.* ; Smida, J. & Atkinson, M.J.: PARTICLE − The RNA podium for genomic silencers. J. Cell. Physiol., accepted (2019)
2.
Papiez, A.* et al.: Integrative multiomics study for validation of mechanisms in radiation-induced ischemic heart disease in Mayak workers. PLoS ONE 13:e0209626 (2018)
3.
O'Leary, V.B. et al.: Long non-coding RNA PARTICLE bridges histone and DNA methylation. Sci. Rep. 7:1790 (2017)
4.
O'Leary, V.B. et al.: The circRNA interactome-innovative hallmarks of the intra- and extracellular radiation response. Oncotarget 8, 78397-78409 (2017)
5.
O'Leary, V.B. et al.: PARTICLE triplexes cluster in the tumor suppressor WWOX and may extend throughout the human genome. Sci. Rep. 7:7163 (2017)
6.
O'Leary, V.B. et al.: The long non-coding RNA PARTICLE is associated with WWOX and the absence of FRA16D breakage in Osteosarcoma patients. Oncotarget 8, 87431-87441 (2017)
7.
Smida, J. et al.: Genome-wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma. Int. J. Cancer 141, 816-828 (2017)
8.
Kovac, M.* et al.: Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency. Nat. Commun. 6:8940 (2015)
9.
Maugg, D. et al.: New small molecules targeting apoptosis and cell viability in osteosarcoma. PLoS ONE 10:e0129058 (2015)
10.
Nathrath, M. ; Smida, J. ; Baumhoer, D. & Kovac, M.*: The genomic landscape in osteosarcoma. Pediatr. Blood Cancer 62, S164 (2015)
11.
Poos, K.* et al.: Genomic heterogeneity of osteosarcoma - shift from single candidates to functional modules. PLoS ONE 10:e0123082 (2015)
12.
Ribi, S.* et al.: TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome. Oncotarget 6, 7727-7740 (2015)
13.
Arabi, L.* et al.: Upregulation of the miR-17-92 cluster and its two paraloga in osteosarcoma - reasons and consequences. Genes Cancer 5, 56-63 (2014)
14.
Baumhoer, D. et al.: Osteosarcomas of the jaws differ from their peripheral counterparts and require a distinct treatment approach. Experiences from the DOESAK registry. Oral Oncol. 50, 147-153 (2014)
15.
Poos, K.* et al.: Structuring osteosarcoma knowledge: An osteosarcoma-gene association database based on literature mining and manual annotation. Database 2014:bau042 (2014)
16.
Poos, K.* et al.: How microRNA and transcription factor co-regulatory networks affect osteosarcoma cell proliferation. PLoS Comput. Biol. 9:e1003210 (2013)
17.
Baumhoer, D. et al.: MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in osteosarcoma. Cancer Genet. 205, 212-219 (2012)
18.
Baumhoer, D. et al.: Strong expression of CXCL12 is associated with a favorable outcome in osteosarcoma. Mod. Pathol. 25, 522-528 (2012)
19.
Rumenapp, C. et al.: Secondary radiation-induced bone tumours demonstrate a high degree of genomic instability predictive of a poor prognosis. Curr. Genomics 13, 433-437 (2012)
20.
Baumhoer, D. et al.: Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma. Hum. Pathol. 42, 859-866 (2011)